Figures computed from official regulatory filings — .
Ownershipinsiders 5.74% · institutions 7.11% · short 0.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for PharmaCyte Biotech, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
6 buysbar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| WEINSTEIN ROBERTtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| WALKER WAYNE REMELL | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Abecassis Michael M | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| SCHECHTER JONATHANtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| SCHECHTER JONATHANtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Abecassis Michael M | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WEINSTEIN ROBERTtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SCHECHTER JONATHANtrack record | Buy | $16.8K | conv 36 | SEC |
| Silverman Joshuatrack record | Buy | $23.4K | conv 41First in 12mo | SEC |
| SCHECHTER JONATHANtrack record | Buy | $15.8K | conv 37 | SEC |
| Silverman Joshuatrack record | Buy | $23.7K | conv 35 | SEC |
| SCHECHTER JONATHANtrack record | Buy | $15.6K | conv 38 | SEC |
| Silverman Joshuatrack record | Buy | $33.2K | conv 36 | SEC |
| WEINSTEIN ROBERTtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WALKER WAYNE REMELL | Other | $17.2K | SEC |
| SCHECHTER JONATHANtrack record | Other | $68.9K | SEC |
| Abecassis Michael M | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Abecassis Michael M | Other | $17.2K | SEC |
| WALKER WAYNE REMELL | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Silverman Joshuatrack record | Other | $263.9K | Unusual size | SEC |
| SCHECHTER JONATHANtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Abecassis Michael M | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WALKER WAYNE REMELL | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SCHECHTER JONATHANtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Silverman Joshuatrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |